| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Depression and anxiety in women 6 months after hypertensive pregnancy: A Blood Pressure Postpartum (BP2) sub-study
|
Su, Virginia
|
|
|
25 |
S1 |
p. e60
|
artikel
|
| 2 |
ES-2. Integrity and usefulness of research in pre-eclampsia
|
Mol, Ben W.
|
|
|
25 |
S1 |
p. e3
|
artikel
|
| 3 |
ES-1. Pre-eclampsia: a view of global issues and advances
|
von Dadelszen, Peter
|
|
|
25 |
S1 |
p. e3
|
artikel
|
| 4 |
Exploring proteomics in the search of novel predictive cardiovascular biomarkers for preeclampsia
|
Nordlöf Callbo, Paliz
|
|
|
25 |
S1 |
p. e46
|
artikel
|
| 5 |
GS-4. Epidemiology of preeclampsia
|
Antsaklis, Panos
|
|
|
25 |
S1 |
p. e16
|
artikel
|
| 6 |
GS-1. First 1000 days of life and non communicable diseases nexus
|
Gupte, Sanjay
|
|
|
25 |
S1 |
p. e15
|
artikel
|
| 7 |
GS-5. Gestosis score a practical tool to predict and risk stratify preeclampsia-gestosis
|
Wagh, Girija
|
|
|
25 |
S1 |
p. e16
|
artikel
|
| 8 |
GS-2. It all comes down to timing of delivery
|
Vidaeff, Alex C.
|
|
|
25 |
S1 |
p. e15-e16
|
artikel
|
| 9 |
GS-3. Prevention and prediction of preeclampsia
|
Antsaklis, Aris
|
|
|
25 |
S1 |
p. e16
|
artikel
|
| 10 |
O-001. Acute cardiovascular and hemodynamic consequences of placental growth factor administration in guinea pigs
|
Tan, Adelene Y.
|
|
|
25 |
S1 |
p. e25
|
artikel
|
| 11 |
O-010. Annual BMI gain is associated with the risk of HDP in the subsequent pregnancy
|
Tano, Sho
|
|
|
25 |
S1 |
p. e28
|
artikel
|
| 12 |
O-007. Beneficial effect of Protease-activated receptor 2 (PAR2) on pregnancy
|
Takahashi, Nobuyuki
|
|
|
25 |
S1 |
p. e27
|
artikel
|
| 13 |
O-002. Beneficial Role of sodium nitrate on pregnancy in mice lacking eNOS
|
Takahashi, Nobuyuki
|
|
|
25 |
S1 |
p. e25
|
artikel
|
| 14 |
O-005. Circulating biomarkers for neurological complications in preeclampsia
|
Bergman, Lina
|
|
|
25 |
S1 |
p. e26-e27
|
artikel
|
| 15 |
O-004. Circulating SIGLEC6 is deranged in preeclampsia and may be a biomarker of disease severity
|
Kaitu'u-Lino, Tu'uhevaha J.
|
|
|
25 |
S1 |
p. e26
|
artikel
|
| 16 |
O-008. Influence of Hypertension in Pregnancy on Hematological Phenotypes of Preterm Infants with Gestational Age Inferior to 32 Weeks
|
Martins, Mariza
|
|
|
25 |
S1 |
p. e27-e28
|
artikel
|
| 17 |
O-009. Intrauterine exposure to hypertensive disorders of pregnancy and postnatal growth in extremely and very preterm infants
|
Ushida, Takafumi
|
|
|
25 |
S1 |
p. e28
|
artikel
|
| 18 |
O-006. Modulatory effect of two regimens of magnesium sulfate on the systemic inflammatory response in pregnant women with eclampsia or imminent eclampsia
|
Peracoli, Jose C.
|
|
|
25 |
S1 |
p. e27
|
artikel
|
| 19 |
O-011. Pre-pregnancy stress leads to impaired placental development, post-partum high blood pressure and vascular dysfunction
|
Powers, Robert W.
|
|
|
25 |
S1 |
p. e28
|
artikel
|
| 20 |
OP-1. The history of maternal-child health handbook and current issues of perinatal mental health in Japan
|
Takeda, Satoru
|
|
|
25 |
S1 |
p. e2
|
artikel
|
| 21 |
O-003. Roles of histidine-rich glycoprotein in prevention of hypertensive disorders of pregnancy and in physiological placental development
|
Teshigawara, Kiyoshi
|
|
|
25 |
S1 |
p. e26
|
artikel
|
| 22 |
P-080. A case of pheochromocytoma in pregnancy complicated with white coat hypertension
|
Kimura, Miwa
|
|
|
25 |
S1 |
p. e55
|
artikel
|
| 23 |
P-073. A case of preeclampsia complicated with posterior reversible encephalopathy syndrome and central serous chorioretinopathy
|
Seo, Naomi
|
|
|
25 |
S1 |
p. e53
|
artikel
|
| 24 |
P-058. A comparison of the effects of placenta-derived extracellular vesicles from preeclamptic and uncomplicated pregnancies on endothelial-dependent vascular function
|
Villalobos-Labra, Roberto
|
|
|
25 |
S1 |
p. e48
|
artikel
|
| 25 |
P-060. adverse effects of the use of magnesium sulfate in a patient with preeclampsia
|
Malandrin, Marcela C.
|
|
|
25 |
S1 |
p. e48
|
artikel
|
| 26 |
P-001. AI_PREMie: A novel risk stratification tool for preeclamptic-toxaemia
|
Szklanna, Paulina B.
|
|
|
25 |
S1 |
p. e29
|
artikel
|
| 27 |
P-091. Ambulatory blood pressure parameters in maternal hypotension: Smooth subtype of short-term blood pressure rhythms
|
Deng, Wenfeng
|
|
|
25 |
S1 |
p. e58-e59
|
artikel
|
| 28 |
P-018. Analysis of subpopulation of exosomes in prospective samples before the onset of preeclampsia
|
Hashimoto, Ayako
|
|
|
25 |
S1 |
p. e34-e35
|
artikel
|
| 29 |
P-004. A novel use of β3 adrenergic receptor agonist in treating preeclampsia
|
Liu, Chia-chi
|
|
|
25 |
S1 |
p. e30
|
artikel
|
| 30 |
P-095. Antithrombin gamma treatment in Japanese patients with early-onset severe preeclampsia: The study protocol of a randomized phase 3 trial (KOUNO-TORI)
|
Saito, Shigeru
|
|
|
25 |
S1 |
p. e60
|
artikel
|
| 31 |
P-083. Aortic Dissection during pregnancy: A case report
|
V Cunha Filho, Edson
|
|
|
25 |
S1 |
p. e56
|
artikel
|
| 32 |
P-071. Application of fullpiers as predictor of neonatal outcomes in pre-eclampsia
|
Gaspar, Luiza B.
|
|
|
25 |
S1 |
p. e52
|
artikel
|
| 33 |
P-007. Are there differences in the decidualizing endometrial secretome in women with recurrent pre-eclampsia?
|
Moran, Olivia C.
|
|
|
25 |
S1 |
p. e31
|
artikel
|
| 34 |
P-088. Aspirin and the risk of birthing a small for gestational age infant; A Swedish population-based study
|
Hastie, Roxanne
|
|
|
25 |
S1 |
p. e57-e58
|
artikel
|
| 35 |
P-044. Assessing long-term cardiovascular effects of hypertension in an L-NAME mouse model of preeclampsia
|
de Alwis, Natasha
|
|
|
25 |
S1 |
p. e43
|
artikel
|
| 36 |
P-053. Association between fasting plasma glucose level at less than 24 weeks of gestation and hypertensive disorders of pregnancy: The BOSHI study
|
Izumi, Seiya
|
|
|
25 |
S1 |
p. e46
|
artikel
|
| 37 |
P-024. Association between office blood pressure levels at 11–13 weeks gestation and the development of hypertension requiring treatment
|
Koide, Keiko
|
|
|
25 |
S1 |
p. e36-e37
|
artikel
|
| 38 |
P-026. Association between vascular remodeling biomarkers and the placentary bed in pre-eclampsy
|
Damasceno, Beatriz R.B.
|
|
|
25 |
S1 |
p. e37
|
artikel
|
| 39 |
P-009. Associations between circulating sFlt-1 and PlGF and preeclampsia with severe maternal complications, or eclampsia
|
Hastie, Roxanne
|
|
|
25 |
S1 |
p. e32
|
artikel
|
| 40 |
P-038. A survey for the need and potential acceptance for AI-based decision support tools in Obstetric Medicine
|
Hackeloeer, Max
|
|
|
25 |
S1 |
p. e41
|
artikel
|
| 41 |
P-075. A survey on the diagnosis and management of uteroplacental dysfunction in hypertensive disorders of pregnancy in Japan
|
Mimura, Kazuya
|
|
|
25 |
S1 |
p. e53
|
artikel
|
| 42 |
P-082. A systematic review of cardiovascular disease prevention targeting lifestyle risk factors in women. Can the evidence inform post-partum health care after hypertensive disorders of pregnancy?
|
Slater, Kaylee
|
|
|
25 |
S1 |
p. e55-e56
|
artikel
|
| 43 |
P-035. Behavioral risk factors of cardiovascular diseases in pregnant women. Prevalence and socioeconomic predictors in Burkina Faso: a cross-sectional study
|
Franck, Garanet
|
|
|
25 |
S1 |
p. e40
|
artikel
|
| 44 |
P-067. Biomarkers profiles of hypertensive disorders of pregnancy on term gestational period: revival of von Willebrand factor
|
Furuya, Kiichiro
|
|
|
25 |
S1 |
p. e51
|
artikel
|
| 45 |
P-066. Blood pressure as a risk factor for eclampsia and pulmonary oedema in pre-eclampsia
|
van Heerden, Pauli
|
|
|
25 |
S1 |
p. e50-e51
|
artikel
|
| 46 |
P-039. Building clinically usable machine-learning models for outcome predicition in preeclampsia
|
Rieger, Oliver S.
|
|
|
25 |
S1 |
p. e41
|
artikel
|
| 47 |
P-033. Changes of natural cytotoxicity receptors of CD56dim and CD56bright NK cells in peripheral blood and decidua in preeclampsia
|
Yamamoto, Tatsuo
|
|
|
25 |
S1 |
p. e39-e40
|
artikel
|
| 48 |
P107. Characteristics of pre-hospital care of pregnant women with hypertensive syndrome
|
Intrieri, Aline C.U.
|
|
|
25 |
S1 |
p. e64
|
artikel
|
| 49 |
P-042. Circulating sFLT1 is sufficient to impair spiral arterial remodeling in mice: Dissecting the maternal and the placental contribution of preeclampsia
|
Vogtmann, Rebekka
|
|
|
25 |
S1 |
p. e42
|
artikel
|
| 50 |
P-104. Clinical characteristics and sequelae of intrapartum hypertension
|
Rajkumar, Theepika
|
|
|
25 |
S1 |
p. e63
|
artikel
|
| 51 |
P-025. Comparison of methods for determining PlGF and sFlt-1 levels in maternal circulation in pregnancies complicated by placental dysfunction
|
Vincent, Kirsty M.M.
|
|
|
25 |
S1 |
p. e37
|
artikel
|
| 52 |
P-003. Complement activation by an angiogenic imbalance leads to systemic vascular endothelial dysfunction
|
Matsuyama, Tatsuya
|
|
|
25 |
S1 |
p. e30
|
artikel
|
| 53 |
P-021. Correlation between cognitive assessment scores and circulating cerebral biomarkers in women with preeclampsia and eclampsia
|
Bokström-Rees, Emma
|
|
|
25 |
S1 |
p. e35-e36
|
artikel
|
| 54 |
P-106. COVID-19 and pre-eclampsia: a literature review
|
Moreira, Heloísa T.B.
|
|
|
25 |
S1 |
p. e63-e64
|
artikel
|
| 55 |
P041. Data mining model as a prediction of pregnancy hypertension with decision tree technique algorithm
|
Fajar, Rifaldy
|
|
|
25 |
S1 |
p. e42
|
artikel
|
| 56 |
P-034. Decreased circulating levels of plasmacytoid dendritic cells in women with early-onset preeclampsia
|
Nagayama, Shiho
|
|
|
25 |
S1 |
p. e40
|
artikel
|
| 57 |
P-040. Development of a machine-learning model to predict adverse outcomes in patients at risk for preeclampsia
|
Schmidt, Leon J.
|
|
|
25 |
S1 |
p. e41-e42
|
artikel
|
| 58 |
P-036. Early onset hypertensive disorders of pregnancy is a high risk phenotype for placental abruption: A Japanese nationwide cohort study
|
Naruse, Katsuhiko
|
|
|
25 |
S1 |
p. e40
|
artikel
|
| 59 |
P-022. Effects of arginase genetic polymorphisms on nitric oxide formation in responsive and nonresponsive preeclampsia women
|
Pinto-Souza, Caroline C.
|
|
|
25 |
S1 |
p. e36
|
artikel
|
| 60 |
P-047. Elevated placental histone H3K4 methylation via upregulated histone methyltransferases in preeclampsia and its possible involvement in hypoxia-induced pathophysiology
|
Matsui, Haruka
|
|
|
25 |
S1 |
p. e44
|
artikel
|
| 61 |
P-093. Elimination of sFLT1 by therapeutic plasma exchange in early-onset preeclampsia/HELLP may improve placental dysfunction and pregnancy duration
|
Duan, Liyan
|
|
|
25 |
S1 |
p. e59
|
artikel
|
| 62 |
P-055. Erythropoietin expression on fetal red blood cells in preeclampsia
|
Chulkov, Vasiliy
|
|
|
25 |
S1 |
p. e47
|
artikel
|
| 63 |
P-086. Establishment of prediction model for hypertensive disorders of pregnancy by time series analysis
|
Moriyama, Yoshinori
|
|
|
25 |
S1 |
p. e57
|
artikel
|
| 64 |
P-002. Evidence of neuroinflammation and injured blood–brain-barrier in eclampsia
|
Bergman, Lina
|
|
|
25 |
S1 |
p. e29-e30
|
artikel
|
| 65 |
P-097. Exploring education preferences of Australian women and healthcare providers regarding long-term health after hypertensive disorders of pregnancy – A qualitative rerspective
|
Roth, Heike
|
|
|
25 |
S1 |
p. e60-e61
|
artikel
|
| 66 |
P-102. Fetal growth restriction as the initial findings of preeclampsia is a clinical predictor of perinatal prognosis: A single-center retrospective study
|
Takahashi, Masaya
|
|
|
25 |
S1 |
p. e62
|
artikel
|
| 67 |
P-068. Fetal growth restriction in diagnosing preeclampsia is an important diagnostic criterion comparable to organ dysfunction
|
Akiba, Naoya
|
|
|
25 |
S1 |
p. e51
|
artikel
|
| 68 |
P-087. Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy
|
Morikawa, Mamoru
|
|
|
25 |
S1 |
p. e57
|
artikel
|
| 69 |
P-081. Hyperaldosteronism in pregnancy: a case control study
|
Makris, Angela
|
|
|
25 |
S1 |
p. e55
|
artikel
|
| 70 |
P-076. Hypertensive disorder of pregnancy and gestational diabetes mellitus
|
Tojieva, Iroda
|
|
|
25 |
S1 |
p. e54
|
artikel
|
| 71 |
P-092. Implementation of angiogenic biomarkers for the diagnosis of pre-eclampsia in Greater Manchester
|
Tomlinson, Emma
|
|
|
25 |
S1 |
p. e59
|
artikel
|
| 72 |
P-103. Incidence and clinical characteristics of hypotension in pregnancy
|
Guo, Lanlan
|
|
|
25 |
S1 |
p. e62-e63
|
artikel
|
| 73 |
P-046. Intensive blood pressure control in chronically hypertensive mice
|
Welsh, Mikala
|
|
|
25 |
S1 |
p. e44
|
artikel
|
| 74 |
P-005. Involvement of RAGE pathway in visceral adipose tissue in preeclampsia
|
Akasaka, Juria
|
|
|
25 |
S1 |
p. e30-e31
|
artikel
|
| 75 |
P-054. Maternal hemodynamics assessed by USCOM® device in patients with hypertensive disorders of pregnancy during peripartum
|
Zhong, Junmin
|
|
|
25 |
S1 |
p. e46-e47
|
artikel
|
| 76 |
P-098. Motivations for reducing cardiovascular risk after hypertensive pregnancy ([LDQUO]not just doing this for me[RDQUO]): a Blood Pressure Postpartum (BP2) sub-study
|
Henry, Amanda
|
|
|
25 |
S1 |
p. e61
|
artikel
|
| 77 |
P-013. Negative predictive value of sFlt-1/PlGF ratio ≤ 38 for ruling out preeclampsia within 1–4 weeks of testing: A secondary analysis of the INSPIRE trial
|
Sofia Cerdeira, A.
|
|
|
25 |
S1 |
p. e33
|
artikel
|
| 78 |
P-070. Neonatal outcomes in pre-eclampsia: Correlation among clinical and laboratory maternal factors
|
Souza, Thais M.P.
|
|
|
25 |
S1 |
p. e52
|
artikel
|
| 79 |
P-065. New human models of preeclampsia; offering physiologically relevant assays for the development of therapeutics to ameliorate preeclamptic vascular dysfunction
|
Fato, Bianca R.
|
|
|
25 |
S1 |
p. e50
|
artikel
|
| 80 |
P-069. Planned delivery or expectant management for the prevention of adverse pregnancy outcomes in pre-eclampsia: A meta-analysis of individual participant data
|
Beardmore-Gray, Alice
|
|
|
25 |
S1 |
p. e51-e52
|
artikel
|
| 81 |
P-050. Potency of Tokishakuyakusan in treating preeclampsia: Drug repositioning method by in vitro screening of the Kampo library
|
Yagi, Kazunobu
|
|
|
25 |
S1 |
p. e45
|
artikel
|
| 82 |
P-008. Predictive efficacy of sFlt-1/PlGF ratio in risk stratification on Indian hypertensive pregnant population
|
Nagabhushana, Prerana
|
|
|
25 |
S1 |
p. e31-e32
|
artikel
|
| 83 |
P-057. Preeclampsia prediction based on urine peptidome study
|
Muminova, Kamilla T.
|
|
|
25 |
S1 |
p. e47
|
artikel
|
| 84 |
P074. Preeclampsia starting at 17 weeks of gestational age in a twin pregnancy: A case report
|
Cunha FIlho, Edson V.
|
|
|
25 |
S1 |
p. e53
|
artikel
|
| 85 |
P-101. Pregnancy and infant outcomes for golimumab therapy for ulcerative colitis during the pregnancy and lactation periods: a retrospective report
|
Miyai, Ayami
|
|
|
25 |
S1 |
p. e62
|
artikel
|
| 86 |
P-108. Pregnancy-associated stroke – frequency and course of subsequent pregnancies
|
Karjalainen, Liisa
|
|
|
25 |
S1 |
p. e64
|
artikel
|
| 87 |
P-019. Pre-pregnancy maternal stress leads to impaired vascular function during pregnancy
|
Powers, Robert W.
|
|
|
25 |
S1 |
p. e35
|
artikel
|
| 88 |
P-059. Prevalence and risk analysis of early-onset and late-onset of hypertensive disorders of pregnancy
|
Nagata, Koh
|
|
|
25 |
S1 |
p. e48
|
artikel
|
| 89 |
P-099. Previous preeclampsia and its association with future cardiovascular diseases: A systematic review and meta-analysis
|
Cavalli, Ricardo
|
|
|
25 |
S1 |
p. e61
|
artikel
|
| 90 |
P063. Pro- and anti-angiogenic factors in hypertensive disorders of pregnancy in women of African ancestry
|
Soobryan, Nerolen
|
|
|
25 |
S1 |
p. e49-e50
|
artikel
|
| 91 |
P-105. Probiotics supplementation increases the risk for preeclampsia
|
Dekker Nitert, Marloes
|
|
|
25 |
S1 |
p. e63
|
artikel
|
| 92 |
P-078. Profile of cesarean delivery care in hypertensive pregnant women
|
Delgado, Isabella
|
|
|
25 |
S1 |
p. e54
|
artikel
|
| 93 |
P-056. Profound changes in hemodynamics proving late-onset PE being of maternal origin
|
Muminova, Kamilla T.
|
|
|
25 |
S1 |
p. e47
|
artikel
|
| 94 |
P-100. Retinal microvascular oxygen saturation in women 3 years after hypertensive disorders of pregnancy
|
Hoel, Sissel
|
|
|
25 |
S1 |
p. e61-e62
|
artikel
|
| 95 |
P-037. Revisiting ‘3 delays model[StQuote] for critical analysis of hypertensive maternal mortality in a developing nation
|
Mehrotra, Seema
|
|
|
25 |
S1 |
p. e41
|
artikel
|
| 96 |
P-029. Role of Placental growth factor for prediction of preeclampsia in first trimester of pregnancy
|
Lata Verma, Manju
|
|
|
25 |
S1 |
p. e38
|
artikel
|
| 97 |
P-014. Role of sFlt-1/PlGF as a predictor of small for gestational age
|
Chiu, Selina
|
|
|
25 |
S1 |
p. e33
|
artikel
|
| 98 |
P-089. SAFE@HOME: Cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia
|
van den Heuvel, Josephus F.M.
|
|
|
25 |
S1 |
p. e58
|
artikel
|
| 99 |
P-077. Self-monitoring of blood pressure in women with higher risk pregnancies: The BUMP1 multicentre randomised controlled trial
|
Tucker, Katherine L
|
|
|
25 |
S1 |
p. e54
|
artikel
|
| 100 |
P-094. Self-monitoring of blood pressure in women with pregnancy hypertension: The BUMP2 multicentre randomised controlled trial
|
Chappell, Lucy C
|
|
|
25 |
S1 |
p. e59-e60
|
artikel
|
| 101 |
P-072. Severe anemia and preeclampsia – Case report and literature review
|
Kawabata, Ikuno
|
|
|
25 |
S1 |
p. e52
|
artikel
|
| 102 |
P-011. sFLT-1, PLGF e sFLT-1/PLGF levels in preeclampsia: correlation with mediated maternal results
|
Filho, Ademar P.S.
|
|
|
25 |
S1 |
p. e32-e33
|
artikel
|
| 103 |
PS-1. Future interaction among International Society of Hypertension (ISH), Japan Society of Hypertension (JSH) and ISSHP
|
Itoh, Hiroshi
|
|
|
25 |
S1 |
p. e2-e3
|
artikel
|
| 104 |
P-010. Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio in pregnant women with suspected preeclampsia
|
Yamazaki, Tomomi
|
|
|
25 |
S1 |
p. e32
|
artikel
|
| 105 |
P085. Should we consider Hypertensive Disorders of Pregnancy a risk factor for postpartum haemorrhage?
|
Caamina Alvarez, Sara
|
|
|
25 |
S1 |
p. e56-e57
|
artikel
|
| 106 |
P-079. Significance of hemodynamic indices in prediction of blood pressure elevation in pregnant women with chronic hypertension
|
Nakanishi, Atsushi
|
|
|
25 |
S1 |
p. e54-e55
|
artikel
|
| 107 |
P-032. Silibinin downregulates the expression of the Th1 and Th17 profiles by the modulation of STATs and transcription factors in pregnant women with preeclampsia
|
Ribeiro, Vanessa R.
|
|
|
25 |
S1 |
p. e39
|
artikel
|
| 108 |
P-043. Simvastatin attenuates the symptoms of preeclampsia murine model
|
Inaba, Kei
|
|
|
25 |
S1 |
p. e42-e43
|
artikel
|
| 109 |
PS-2. Pregnancy and kidney disease
|
Kashihara, Naoki
|
|
|
25 |
S1 |
p. e3
|
artikel
|
| 110 |
P-048. Stringent laboratory monitoring of pre-eclampsia and gestational hypertension: Improving care in low-resource settings
|
Chibuoke Ngene, Nnabuike
|
|
|
25 |
S1 |
p. e44-e45
|
artikel
|
| 111 |
P-028. Study of mean platelet volume in first trimester of pregnancy and its association with development of preeclampsia
|
Solanki, Vandana
|
|
|
25 |
S1 |
p. e38
|
artikel
|
| 112 |
P-016. Sub-analysis of the Japanese population from PROGNOSIS Asia study assessing the sFlt-1/PlGF ratio for short-term prediction of preeclampsia
|
Ohkuchi, Akihide
|
|
|
25 |
S1 |
p. e34
|
artikel
|
| 113 |
P-061. Successful vaginal delivery in pregnant women with preeclampsia undergoing labor induction with Prostaglandin
|
Sassatani, Yuri R.
|
|
|
25 |
S1 |
p. e49
|
artikel
|
| 114 |
P-062. Success of vaginal parturiation in pregnant women with preeclampsia submitted to induction of delivery after cervical ripening
|
Vettorazzo, Beatrzi G.
|
|
|
25 |
S1 |
p. e49
|
artikel
|
| 115 |
P-084. Symptomatic SARS-COV-2 infected pregnant patients and preeclampsia: worse outcome?
|
Marins, Lina R
|
|
|
25 |
S1 |
p. e56
|
artikel
|
| 116 |
P-012. The association of sFlt-1: PlGF ratio with systematic damage in patient at increased risk of hypertensive disorders during pregnancy
|
Mao, Di
|
|
|
25 |
S1 |
p. e33
|
artikel
|
| 117 |
P-049. The efficacy of discontinuing the use of low-dose aspirin at 28 weeks of gestation for preventing preeclampsia
|
Kawaguchi, Haruna
|
|
|
25 |
S1 |
p. e45
|
artikel
|
| 118 |
P-017. The Elecsys sFlt-1/PlGF ratio for short-term prediction of preeclampsia in the Japanese cohort of the PROGNOSIS Asia study: Economic evaluation
|
Ohkuchi, Akihide
|
|
|
25 |
S1 |
p. e34
|
artikel
|
| 119 |
P-006. The pathophysiological role of calreticulin in maternal circulation for preeclampsia
|
Iwahashi, Naoyuki
|
|
|
25 |
S1 |
p. e31
|
artikel
|
| 120 |
P-027. The prognostic role of maternal angiogenic markers in suspected pre-eclampsia in twin pregnancies
|
Pattanasri, Melinda
|
|
|
25 |
S1 |
p. e37-e38
|
artikel
|
| 121 |
P-020. The relationship of the parameter of ambulatory blood pressure monitoring and bio-marker in women with hypertensive disorders of pregnancy
|
Di, Xiaodan
|
|
|
25 |
S1 |
p. e35
|
artikel
|
| 122 |
P-064. The significance of chest X-ray abnormalities early in the third trimester of twin pregnancies, its relationship with develpoment of preeclampsia
|
Yagi, Kazunobu
|
|
|
25 |
S1 |
p. e50
|
artikel
|
| 123 |
P-090. User experiences with and recommendations for mobile health technology for hypertensive disorders of pregnancy: Mixed methods study
|
van den Heuvel, Josephus F.M.
|
|
|
25 |
S1 |
p. e58
|
artikel
|
| 124 |
P-023. Uterine vascular resistance and other maternal factors associated with the risk of developing hypertension during pregnancy
|
Cavalli, Ricardo
|
|
|
25 |
S1 |
p. e36
|
artikel
|
| 125 |
P-045. VEGFR/SFlt1 is associated to disruption of oxidative stress leading to endothelial dysfunction in preeclampsia
|
Matos, Andreia
|
|
|
25 |
S1 |
p. e43
|
artikel
|
| 126 |
P-031. Vitamin D maintains viability and decreases apoptosis in huvec and modulates inflammation in placenta from preeclamptic women cultured with TNF-α
|
Nunes, Priscila R.
|
|
|
25 |
S1 |
p. e39
|
artikel
|
| 127 |
P-030. Vitamin D modulates inflammasomes in placental explants of preeclamptic women and decreased apoptosis in HUVEC cultured with monosodium urate
|
Nunes, Priscila R.
|
|
|
25 |
S1 |
p. e38-e39
|
artikel
|
| 128 |
Retrospective study for classifying hypertensive disorders of pregnancy by time of onset
|
Nakamura, Eishin
|
|
|
25 |
S1 |
p. e45
|
artikel
|
| 129 |
Reviewers
|
|
|
|
25 |
S1 |
p. e65
|
artikel
|
| 130 |
SA. RNA interference therapy for preeclampsia
|
Ananth Karumanchi, S.
|
|
|
25 |
S1 |
p. e2
|
artikel
|
| 131 |
SY3-2. Adipokine/Lipokine and inflammatory process in preeclampsia
|
Naruse, Katsuhiko
|
|
|
25 |
S1 |
p. e6
|
artikel
|
| 132 |
SY5-4. An update on current and emerging therapies to treat or prevent preeclampsia
|
Tong, Stephen
|
|
|
25 |
S1 |
p. e8
|
artikel
|
| 133 |
SY10-4. Atypical Hemolytic Uremic Syndrome and Pregnancy
|
Maruyama, Shoichi
|
|
|
25 |
S1 |
p. e13
|
artikel
|
| 134 |
SY7-4. Blood pressure after normal and pre-eclamptic pregnancy
|
Brown, M.A.
|
|
|
25 |
S1 |
p. e10
|
artikel
|
| 135 |
SY10-3. Complement Activation and Regulation in Preeclampsia and HELLP Syndrome
|
Burwick, Richard M.
|
|
|
25 |
S1 |
p. e13
|
artikel
|
| 136 |
SY1-2. COMT in the biology of preeclampsia
|
Kanasaki, Keizo
|
|
|
25 |
S1 |
p. e4
|
artikel
|
| 137 |
SY10-1. Differential diagnosis of pregnancy-associated thrombotic microangiopathies (TTP, aHUS, and HELLP syndrome)
|
Matsumoto, Masanori
|
|
|
25 |
S1 |
p. e12-e13
|
artikel
|
| 138 |
SY2-1. Enhanced adenosine signaling in the placenta: a crucial pathogenic factor and a possible therapeutic target for preeclampsia
|
Iriyama, Takayuki
|
|
|
25 |
S1 |
p. e4
|
artikel
|
| 139 |
SY4-3. Expectant management of preeclampsia
|
Kondoh, Eiji
|
|
|
25 |
S1 |
p. e7
|
artikel
|
| 140 |
SY9-2. Hypertensive disorders of pregnancy and future maternal cardiovascular health
|
Wu, Pensée
|
|
|
25 |
S1 |
p. e11-e12
|
artikel
|
| 141 |
SY3-1. Long-term consequences of pregnancy complications: lessons from mouse models
|
Plösch, Torsten
|
|
|
25 |
S1 |
p. e5
|
artikel
|
| 142 |
SY7-2. Management of hypertensive disorders of pregnancy based on home blood pressure
|
Metoki, Hirohito
|
|
|
25 |
S1 |
p. e10
|
artikel
|
| 143 |
SY10-2. Management of severe postpartum TMA
|
Makino, Shintaro
|
|
|
25 |
S1 |
p. e13
|
artikel
|
| 144 |
SY8-1. Maternal diet and gut microbiota: effects on gut blood pressure and metabolism
|
Nitert, Dekker
|
|
|
25 |
S1 |
p. e10-e11
|
artikel
|
| 145 |
SY8-2. Maternal immunological changes and the gut microbiome during pregnancy
|
Faas, Marijke
|
|
|
25 |
S1 |
p. e11
|
artikel
|
| 146 |
SY5-3. Maternal mortality: how can lives are saved?
|
Ikeda, Tomoaki
|
|
|
25 |
S1 |
p. e8
|
artikel
|
| 147 |
SY4-2. Non-coding RNAs in extravillous trophoblast cells
|
Takizawa, Toshihiro
|
|
|
25 |
S1 |
p. e6-e7
|
artikel
|
| 148 |
SY6-2. Possible role of statin to prevent preeclampsia
|
Ilham Aldika Akbar, Muhammad
|
|
|
25 |
S1 |
p. e9
|
artikel
|
| 149 |
SY3-3. Possible role of the NLRP3 inflammasome in preeclampsia
|
Shirasuna, Koumei
|
|
|
25 |
S1 |
p. e6
|
artikel
|
| 150 |
SY9-1. Predicting and preventing long-term cardiovascular disease after preeclampsia
|
Cathrine Staff, Anne
|
|
|
25 |
S1 |
p. e11
|
artikel
|
| 151 |
SY1-1. Pre-eclampsia, syncytiotrophoblast stress and the ‘twilight placenta’
|
Redman, C.W.G.
|
|
|
25 |
S1 |
p. e3-e4
|
artikel
|
| 152 |
SY6-3. RCT: Pravastatin vs. placebo for prevention of term preeclampsia
|
Döbert, Moritz
|
|
|
25 |
S1 |
p. e9
|
artikel
|
| 153 |
SY4-1. Reliable urinary screening tests for preeclampsia
|
Scioscia, Marco
|
|
|
25 |
S1 |
p. e6
|
artikel
|
| 154 |
SY9-3. Rheumatic diseases and HDP
|
Murashima, Atsuko
|
|
|
25 |
S1 |
p. e12
|
artikel
|
| 155 |
SY4-4. Role of sFlt-1 on the development of preeclampsia: basic and clinical approach
|
Suzuki, Hirotada
|
|
|
25 |
S1 |
p. e7
|
artikel
|
| 156 |
SY5-2. Simplified prediction criteria and management of preeclampsia for LMIC
|
Gupte, Sanjay
|
|
|
25 |
S1 |
p. e8
|
artikel
|
| 157 |
SY6-1. Statins for preeclampsia
|
Kumasawa, Keiichi
|
|
|
25 |
S1 |
p. e9
|
artikel
|
| 158 |
SY4-5. Temporary hypertension as well as white coat hypertension in the first trimester as risk factors for preeclampsia
|
Hirashima, Chikako
|
|
|
25 |
S1 |
p. e7
|
artikel
|
| 159 |
SY9-5. The approaches and problems in the care of the postpartum women who suffered from hypertensive disorders of pregnancy
|
Mito, Asako
|
|
|
25 |
S1 |
p. e12
|
artikel
|
| 160 |
SY2-2. The development of preeclampsia hypotheses in the last two decades: what has been disproved and what is still valid?
|
Huppertz, Berthold
|
|
|
25 |
S1 |
p. e4-e5
|
artikel
|
| 161 |
SY2-3. The role of autophagy in pathophysiology of PE
|
Nakashima, Akitoshi
|
|
|
25 |
S1 |
p. e5
|
artikel
|
| 162 |
SY9-4. The role of exercise in the prevention of preeclampsia and gestational hypertension
|
Davenport, Margie
|
|
|
25 |
S1 |
p. e12
|
artikel
|
| 163 |
SY8-3. The role of the microbiome in reproduction
|
Schoenmakers, Sam
|
|
|
25 |
S1 |
p. e11
|
artikel
|
| 164 |
SY7-1. Timing of delivery and blood pressure cutoff for chronic hypertension during pregnancy before and after ACC/AHA 2017
|
Sisti, Giovanni
|
|
|
25 |
S1 |
p. e9-e10
|
artikel
|
| 165 |
SY5-1. Timing of delivery in late preterm pre-eclampsia
|
Chappell, Lucy
|
|
|
25 |
S1 |
p. e8
|
artikel
|
| 166 |
SY7-3. Trials of IT based-telemonitoring of blood pressure for pregnant women at higher risk: an overview of the BUMP trials
|
McManus, Richard
|
|
|
25 |
S1 |
p. e10
|
artikel
|
| 167 |
SY1-3. Trophoblast extracellular vesicles in preeclampsia
|
Vatish, Manu
|
|
|
25 |
S1 |
p. e4
|
artikel
|
| 168 |
SY2-4. What is new n 2021 concerning late onset preeclampia (70-80% of preeclampsia cases): Maternal pre-pregnancy BMI
|
Robillard, Pierre-Yves
|
|
|
25 |
S1 |
p. e5
|
artikel
|
| 169 |
Welcome Message by Congress Chair of ISSHP 2021
|
|
|
|
25 |
S1 |
p. e1
|
artikel
|
| 170 |
WS-4. A multicenter prospective study of home blood pressure measurement during pregnancy in Japanese women
|
Watanabe, Kazushi
|
|
|
25 |
S1 |
p. e14-e15
|
artikel
|
| 171 |
WS-2. Dysregulation of autotaxin-lysophosphatidic acid signaling system in preeclamptic placenta
|
Nagamatsu, Takeshi
|
|
|
25 |
S1 |
p. e14
|
artikel
|
| 172 |
WS-5. Proposal for a novel classification based on onset of HDP; antenatal onset, labor onset, and postpartum onset
|
Ohno, Yasumasa
|
|
|
25 |
S1 |
p. e15
|
artikel
|
| 173 |
WS-3. The importance of lifestyle interventions
|
Nakamura, Satoko
|
|
|
25 |
S1 |
p. e14
|
artikel
|
| 174 |
WS-1. The significance of proteinuria among pregnant women with preeclampsia
|
Morikawa, Mamoru
|
|
|
25 |
S1 |
p. e14
|
artikel
|
| 175 |
Y-008. Accurate prediction of total PlGF from free PlGF and sFlt-1: Evidence for markedly elevated PlGF levels in acute fatty liver of pregnancy
|
Neuman, Rugina I.
|
|
|
25 |
S1 |
p. e19-e20
|
artikel
|
| 176 |
Y-005. Altered placental morphology results in impaired fetal organ development in hsFLT1-transgenic mice: first signs of fetal programming in preeclampsia?
|
Vogtmann, Rebekka
|
|
|
25 |
S1 |
p. e18-e19
|
artikel
|
| 177 |
Y-011. Comparison 0f zuspan regime and its 12-hour modification in women with severe pre-eclampsia and eclampsia In two hospitals In Abeokuta, South Western Nigeria
|
Grillo, Elizabeth O.
|
|
|
25 |
S1 |
p. e21
|
artikel
|
| 178 |
Y-002. Dietary magnesium insufficiency induces salt-sensitive hypertension in mice associated with reduced kidney COMT activity
|
Kumagai, Asako
|
|
|
25 |
S1 |
p. e17
|
artikel
|
| 179 |
Y-001. Human trophoblast development is captured by naive induced pluripotent stem cells in vitro
|
Io, Shingo
|
|
|
25 |
S1 |
p. e17
|
artikel
|
| 180 |
Y-015. Hypertensive disorders of pregnancy and alterations in brain metabolites in preterm infants: a multi-voxel proton MR spectroscopy study
|
Katsuki, Satoru
|
|
|
25 |
S1 |
p. e22
|
artikel
|
| 181 |
Y-019. Immunomodulatory effect of vitamin D on the activators of transcription and transcription factors of CD4+ T cell subsets in pregnant women with preeclampsia
|
Ribeiro, Vanessa R.
|
|
|
25 |
S1 |
p. e23-e24
|
artikel
|
| 182 |
Y-016. Interaction between previous preeclampsia and inter-pregnancy chronic hypertension development on preeclampsia risk in the subsequent pregnancy
|
Ragnarsdottir, Inger B.
|
|
|
25 |
S1 |
p. e22
|
artikel
|
| 183 |
Y-004. Investigating nitrate metabolism and the oral microbiome in hypertensive pregnancies
|
Willmott, Thomas
|
|
|
25 |
S1 |
p. e18
|
artikel
|
| 184 |
Y-007. Is the cut-off 38 the best value to predict adverse outcomes in pregnancies with abnormal uterine artery doppler In the second trimestre?
|
Caamina Alvarez, Sara
|
|
|
25 |
S1 |
p. e19
|
artikel
|
| 185 |
Y-003. Longitudinal serum cytokine profiles in gestational hypertension and preeclampsia
|
Jarmund, Anders H.
|
|
|
25 |
S1 |
p. e18
|
artikel
|
| 186 |
Y-012. Metformin changes serum cytokines in pregnant women with polycystic ovary syndrome
|
Ryssdal, Mariell
|
|
|
25 |
S1 |
p. e21
|
artikel
|
| 187 |
Y-018. Placental-derived human sFLT1 accumulates in maternal serum and alters placental and fetal development in transgenic mice
|
Vogtmann, Rebekka
|
|
|
25 |
S1 |
p. e23
|
artikel
|
| 188 |
Y-006. Predicting algorithm for risk of pre-eclampsia using 1st trimester circulating microRNAs
|
Clément, Andrée-Anne
|
|
|
25 |
S1 |
p. e19
|
artikel
|
| 189 |
Y-010. Prediction of hypertensive disorders of pregnancy based on home blood pressure monitoring
|
Ohno, Shuntaro
|
|
|
25 |
S1 |
p. e20
|
artikel
|
| 190 |
Y-017. SAFE@HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia – A case-control study
|
van den Heuvel, Josephus F.M.
|
|
|
25 |
S1 |
p. e23
|
artikel
|
| 191 |
Y-013. The effect of COVID-19 on placental function: a population level and case-control study
|
Wilkinson, Michael
|
|
|
25 |
S1 |
p. e21
|
artikel
|
| 192 |
Y-009. The link between sFlt-1 expression and inflammatory and vascular pathology at the maternal-fetal interface in preeclampsia
|
Rakner, Johanne J.
|
|
|
25 |
S1 |
p. e20
|
artikel
|
| 193 |
Y-014. Two-year infant and maternal outcomes after planned delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial
|
Beardmore-Gray, Alice
|
|
|
25 |
S1 |
p. e22
|
artikel
|
Tijdschrift beschrijving